Press Release


Munich Pittsburgh Lung Conference 2015 – Prominent lung researchers discuss precision medicine

The fifth Munich Lung Conference (MPLC) was held on 2 and 3 October, this year organized together with the University of Pittsburgh. Under the motto “Precision medicine: From molecular mechanisms to targeted therapy” it again drew many top-class international lung research experts and visitors to Munich.

from left: Oliver Eickelberg, Günther Wess, Jürgen Behr, Rama Mallampalli, Mark T. Gladwin. Photo: HMGU

“It is our second joint international conference* and it brings together leading researchers and clinicians working in respiratory medicine to discuss the development of new therapies and establish new approaches in the area of personalized medicine,” explains co-organizer Prof. Dr. Mark Gladwin, Head of the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Vascular Medicine Institute at the University of Pittsburgh, and also a member of the Scientific Advisory Board of the German Center for Lung Research (DZL). 

The attendees used the opportunity for an interdisciplinary scientific exchange during numerous presentations by internationally renowned speakers and selected scientists. The two Poster Sessions also offered a fine opportunity for an informal exchange and for scientific and conceptual discussion. 

The conference gains more attention each year, and has meanwhile established itself as a fixture in the calendars of many lung experts. One of the highlights of the conference was an intensive podium discussion with the editors of the highly respected scientific journals “The Lancet Respiratory Medicine”, “Journal of Clinical Investigation“, “Science Translational Medicine”, and “The American Journal of Respiratory and Critical Care Medicine“. Many conference participants used the opportunity for discourse with the editors. 

“This year's conference revolves around the issue: How to establish better treatment, diagnosis and monitoring for the individual patient. The coming years will see outstanding progress particularly in the area of pulmonary fibrosis, and this conference hosts excellent guests who are laying the foundation here needed to implement these developments in the future,” Prof. Dr. Oliver Eickelberg, Chairman of the Comprehensive Pneumology Center (CPC), Director of the Institute of Lung Biology and Diseases at the Helmholtz Zentrum München (HMGU) and Director of the Munich partner site of the DZL relates.

Many of the attendees continued their scientific discussions in an Oktoberfest atmosphere at the Bavarian Evening organized by the MPLC and used the opportunity to strengthen existing networks and establish new contacts.

To wind up the scientifically very successful conference, prizes were awarded to young scientists and renowned researchers to pay tribute to their outstanding scientific accomplishments. The “Münchner Bank Research Award for Excellence in Pulmonary Research” is offered by the Münchner Bank and the AtemWeg – The Lung Disease Research Foundation. This year two scientists were honoured: Dr. Charly Lai and Prof. Bill Chen, both from the UPMC, received the award. In addition, the MPLC 2015 Poster Prize was awarded to Dr. Gerrit John-Schuster from the CPC and Dr. Josiah Radder from the UPMC.

"This conference again impressively emphasizes the international significance of the Helmholtz Zentrum München and the Comprehensive Pneumology Center with regard to biomedical research in Germany. The many international projects and partnerships that develop here are of particularly special importance with regard to the education of the next generation of researchers," is how Prof. Günther Wess, Scientific Director of Helmholtz Zentrum München describes the event. In this sense, one can already start looking forward to the continuation next year!


The conference is held each year, and has been organized together with the University of Pittsburgh Medical Center (UPMC) since 2014. In Munich, the event is organized by the Comprehensive Pneumology Center under the technical guidance of an international committee with financial support from the Helmholtz Zentrum München, the CPC Research School, the UPMC and the AtemWeg foundation.